Uveitic crystalline maculopathy
© Or et al.; licensee Springer. 2015
Received: 6 November 2014
Accepted: 31 January 2015
Published: 14 February 2015
The purpose of this case report is to present a novel cause of crystalline maculopathy.
A 52-year-old Japanese female presented with a 4-month history of decreased vision in the left eye. Best corrected visual acuity in the left eye was 20/40. Dilated fundus examination of the right eye was unremarkable, but that of the left eye demonstrated foveal yellow-green intraretinal crystals and mild vitritis. Optical coherence tomography of the left eye revealed small intraretinal fluid cysts and intraretinal crystals. Ultra-widefield fluorescein angiography was normal in the right eye, but that of the left eye demonstrated features of intermediate uveitis. There was no history or findings to suggest any cause for the crystals other than the uveitis.
We propose that this may represent a novel category of crystalline retinopathy, termed uveitic crystalline maculopathy. We hypothesize that breakdown of the blood-retinal barrier as seen in uveitis may contribute to the deposition of crystals in the macula, although the precise composition of the crystals is unknown.
Crystalline maculopathies are a group of disorders characterized by hyper-reflective crystalline deposits in the macula with a variety of recognized and proposed etiologies such as toxic, genetic, and degenerative causes . Differentiation between these conditions may be difficult, and diagnosis usually requires a thorough history, including dietary intake and family history, and physical examination, with an emphasis on the nature and distribution of the hyper-reflective crystals. Fluorescein angiography (FA) and optical coherence tomography (OCT) have become useful tests in the evaluation of patients with crystalline maculopathy .
As our understanding of crystalline maculopathy has grown, several specific causes and risk factors have been identified, such as tamoxifen, canthaxanthine, oxalosis, Sjogren-Larsson syndrome, and West African crystalline maculopathy (WACM) . Herein, we present a novel case of crystalline maculopathy associated with uveitis and an absence of recognized risk factors. We propose that this may represent a novel category of crystalline maculopathy, termed uveitic crystalline maculopathy.
There was no family history of African ancestry or a family history of crystalline maculopathy. There was no history of tamoxifen, canthaxanthine, methoxyflurane, and nitrofurantoin exposure; IV drug use; or kola nut consumption. She admitted to eating a diet high in oxalate (spinach, kale, chard). CT of the chest, purified protein derivative (PPD) test for tuberculosis, angiotensin-converting enzyme levels for sarcoidosis, FTA-ABS for syphilis, CBC, urinalysis, serum creatinine, ionized calcium, and 24-h urine oxalate were all normal.
The patient was treated with posterior subtenon triamcinolone (40 mg, Triesence, Alcon Laboratories, Inc., Fort Worth, TX, USA), with little improvement. The patient was then treated with intravitreal triamcinolone (4 mg, Triesence), and the intraretinal fluid subsequently resolved. BCVA improved to 20/30 OS, but the crystals remained.
Our case represents the first described case of uveitic crystalline maculopathy. The clinical characteristics of this case, particularly the characteristics and distribution of the crystals observed, are similar to those of West African crystalline maculopathy. WACM was first reported in 2003 by Sarraf et al. in elderly members of the Igbo Tribe in Nigeria and was characterized by bilateral asymptomatic yellow-green hyper-reflective crystals in the superficial fovea, localized to the layer of Henle on OCT, and hypothesized to be related to kola nut ingestion . Similar reports have subsequently been described in several other regions in West and East Africa, and the role of kola nut ingestion in the pathogenesis of this condition remains under question [3-5]. Browning suggested that diabetes mellitus may contribute to the pathogenesis of WACM, as every patient in his case series had diabetes and the distribution of crystals appeared to correlate with areas of diabetic exudate and retinal edema . This was supported by a subsequent case series by Rajak et al. who noted that all patients in their case study had diabetes or another coexistent retinal pathology that could result in retinal ischemia, such as sickle cell retinopathy or branch macular vein occlusion . It was then postulated that disruptions to the blood-retinal barrier secondary to retinal ischemia in susceptible patients could result in macular crystal formation in WACM, likely as a result of exudation of pre-formed crystals or precipitation from exudated serum . We hypothesize that a similar mechanism underlies the pathogenesis of uveitic crystalline maculopathy, as breakdown of the blood-retinal barrier is fundamental to the development of uveitis. The fact that crystals could only be seen in the eye with uveitis in our case emphasizes its involvement in the pathogenesis of uveitic crystalline maculopathy.
We propose that this case represents a novel category of crystalline maculopathy, one in which uveitis is directly involved in the pathogenesis of the condition. However, the composition of the crystals is still unknown. Further studies are required to fully elucidate the pathogenesis and etiological basis of uveitic crystalline maculopathy.
There are no acknowledgements.
- Drenser K, Sarraf D, Jain A, Small KW (2006) Crystalline retinopathies. Surv Ophthalmol 51:535–49View ArticlePubMedGoogle Scholar
- Sarraf D, Ceron O, Rasheed K, Drenser KA, Casey R (2003) West African crystalline maculopathy. Arch Ophthalmol 121:338–42View ArticlePubMedGoogle Scholar
- Rajak SN, Mohamed MD, Pelosini L (2009) Further insight into West African crystalline maculopathy. Arch Ophthalmol 127:863–8View ArticlePubMedGoogle Scholar
- Hammoudi DS, Mandelcorn E, Navajas EV, Mandelcorn M (2011) A case of African crystalline maculopathy. Eye (Lond) 25:825–7View ArticleGoogle Scholar
- Browning DJ (2004) West African crystalline maculopathy. Ophthalmology 111:921–5View ArticlePubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.